Europe Veterinary Clinical Trials Market Analysis, Trends, Share, 2024 - 2032
Europe Veterinary Clinical Trials Market Analysis, Trends, Share, 2024 - 2032

Europe Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type (Livestock Animal, Companion Animal, Other Animals), By Intervention, By Indication, By End User, and By Country (Germany, France, UK, Italy, Spain, Netherlands, Russia, and the Rest of Europe) – Market Forecast, 2024 - 2032

  • Published Date:Jul-2024
  • Pages: 117
  • Format: PDF
  • Report ID: PM4997
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

healthcare refers to the organized services and systems designed to maintain and improve people's health. It includes prevention, diagnosis, treatment, and recovery, delivered by professionals like doctors, nurses, and medical specialists.

FAQ's

The Europe veterinary clinical trials market size was valued at USD 718.65 million in 2023 and is expected to grow to USD 1,650.57 million in 2032.

The Europe market is projected to grow at a CAGR of 9.7% during the forecast period.

The UK veterinary clinical trials market held the largest market share in 2023.

The key players in the market are Argenta, Veyx-Pharma GmbH, Central VetPharma Consultancy, KLIFOVET GmbH, Boehringer Ingelheim International GmbH, Ondax Scientific, Vivesto AB, Labcorp Drug Development, Merck & Co., Inc., and knoell.

In 2023, the medicines segment accounted for the largest market share.

The academics and research centers segment is expected to witness a significant CAGR in the Europe veterinary clinical trials market during the forecast period.